Compound medicine for preventing and treating cardio vascular cerebral vascular disease and its application

A cardiovascular and cerebrovascular disease and compound technology, applied in the field of chemical drugs, can solve problems such as incompetent prevention and treatment of cardiovascular and cerebrovascular diseases, and achieve the effects of preventing cardiovascular and cerebrovascular events, ensuring curative effect, and reducing dosage.

Inactive Publication Date: 2006-08-30
张士东
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because any single drug is not up to the task of preventing an

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0004] Example 1: This compound medicine is composed of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 2.5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, and 75 mg of aspirin. Preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric-coated capsules, Sustained-release capsules, etc.) preparation process is carried out. For early menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

Embodiment 2

[0005] Example 2: This compound medicine consists of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 5 mg of simvastatin, and 2.0 mg of metoprolol 2 , amlodipine 0.5mg, aspirin 100mg to make combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, Immediate-release tablets, controlled-release tablets, hard capsules, enteric-coated capsules, sustained-release capsules, etc.) preparation process is carried out. For late menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

Embodiment 3

[0006] Example 3: The compound medicine is made of 300 mg of soybean isoflavones and / or 0.05 mg of 17β estrogen, 2.5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, and 40 mg of aspirin. , according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric-coated capsules, sustained-release tablets, Release capsules, etc.) preparation process is carried out. For adult male high-risk groups. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A compound medicine for preventing and treating the cardiovascular and cerebrovascular diseases of climacteric woman and adult man, climacteric syndrome, osteoporosis, endometrial carcinoma, senile dementia, diabetes and metabolism syndrome contains sexual hormones, hypolipemic component, antihypertensive component and anticoagulating component. It features that the ratio of its components is adjustable according to actual disease.

Description

technical field [0001] A compound medicine for preventing and treating cardiovascular and cerebrovascular diseases. It belongs to the field of chemical medicine. Background technique [0002] 1. Cardiovascular and cerebrovascular diseases are the number one killer threatening human health. The morbidity rate is the highest, the mortality rate is the highest, and it is still showing a growing trend. Therefore, it is an urgent task and a social responsibility to find new ideal drugs and therapies, and to control and prevent the development of diseases. 2. Before menopause, the incidence of cardiovascular and cerebrovascular diseases is very low in women, but after menopause, the incidence and mortality are the same as men. At present, it is believed that it may be related to female hormones. 3. A large number of animal experiments and clinical observations show that sex hormones, especially estrogen, can reduce the damage of inflammatory factors to blood vessels, protect d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K45/00A61K31/56A61K9/20A61K9/48A61P15/12A61P15/00A61P9/00A61P3/10A61P3/00A61P35/00
Inventor 吴立群张士东熊世钢李爱民吴立范
Owner 张士东
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap